Bayer: all 1,694 studies
Page 14 of 17. Open to participants first (61), then studies with results posted, then the rest; newest registration first within each.
- Dose-confirmatory Bridging Study in Total Knee ReplacementCompletedNCT01206972Phase 3
- The Safety and toleRability of UltraviSt in Patients Undergoing Cardiac CaTheterization (TRUST)CompletedNCT01206257
- Dose-confirmatory Bridging Study in Total Hip ReplacementCompletedNCT01205932Phase 3
- Investigation of Three Contraceptive Hormone Patches in Regard to Inhibition of Ovulation Following Application Over 3 Treatment Cycles in Healthy, Young Women.CompletedNCT01204190Phase 2
- Assessing BAY86-9766 Plus Sorafenib for the Treatment of Liver Cancer.CompletedNCT01204177Phase 2
- Non-interventional Study on Oral Contraception Not Containing Ethinylestradiol (EE) to Assess Continuation Rates and SatisfactionCompletedNCT01200186
- Study to Investigate Adherence of Patients to Clodronate (Bonefos) TreatmentCompletedNCT01198457
- To Evaluate Compliance to Treatment Regimen (Rate of Deviations From the Prescribed Regimen) in Polish Females Treated With Different Low Dose Oral ContraceptivesCompletedNCT01198444
- Advanced Renal Cell Carcinoma, With Failure or Unsuitable on Prior Interferon-alpha or Interleukin-2 Based TherapyTerminatedNCT01195649
- GIDEON Non-Nexavar Arm - HCC Patients Who Are Treated With Any Therapy Other Than Nexavar at Individual Study StartWithdrawnNCT01191385
- Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 Given in a 3 Days on / 4 Days Off Schedule in Subjects With Advanced MalignanciesCompletedNCT01188252Phase 1
- Long-term Study in Chronic Kidney Disease (Extension From Study 14817)CompletedNCT01187628Phase 3
- Determination of Safety, Efficacy, and Pharmacokinetics of "Regorafenib" Combined With Pemetrexed and Cisplatin in Patients With Nonsquamous Non-Small Cell Lung CancerTerminatedNCT01187615Phase 1
- Data on Oral Contraceptives Compliance in Non Stop RegimenCompletedNCT01185678
- Evaluation of Risk Factors for Early Termination of Injection Treatment With Betaferon in Patients Suffering From Multiple SclerosisCompletedNCT01184833
- Trial to Evaluate the Pharmacokinetics and Safety Profile of BAY94-9027 Following Single and Multiple Dose AdministrationCompletedNCT01184820Phase 1
- Japanese BAY86-9766 Monotherapy Phase I StudyCompletedNCT01179295Phase 1
- A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Diastolic DysfunctionTerminatedNCT01172756Phase 2
- Study in COPD (Chronic Obstructive Pulmonary Disease) Subjects to Investigate Safety, Tolerability, and Pharmacokinetics of Ciprofloxacin After Single Dose Inhalations of 50 mg and 75 mg Ciprofloxacin Inhalation PowderCompletedNCT01168895Phase 1
- Clinical Proof-of-concept Study for the Combination BAY60-4552 / Vardenafil for the Treatment of Erectile Dysfunction Not Sufficiently Responsive to Standard Therapy With PDE5 InhibitorsCompletedNCT01168817Phase 2
- Prevention of Postprandial Hyperglycemia by Acarbose May be a Promising Therapeutic Strategy for Reducing the Increased Risk for Cardiovascular DiseaseCompletedNCT01167231
- Coronary Vasomotor Response After Riociguat ExposureWithdrawnNCT01165931Phase 2
- A Prospective Observational Study to Evaluate the Quality of Life and the Costs in a Real Life Setting in Patients Who Are Treated With 90Y-ZevalinCompletedNCT01164696
- A Study to Evaluate The Effects Of a Multivitamin/Mineral With Ginko In Subjects With Age Associated Memory ImpairmentCompletedNCT01160692Phase 3
- Prophylaxis Versus On-demand Therapy Through Economic ReportCompletedNCT01159587
- Real-World Betaseron Health Economic Outcomes Study for Relapsing Forms of Multiple SclerosisCompletedNCT01158183
- Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric SubjectsCompletedNCT01145859Phase 1
- Evaluate Analgesic Efficacy of Fast Release AspirinCompletedNCT01122602Phase 3
- Treatment of Hypertension With Adalat® in Combination With Other DrugsCompletedNCT01118286
- Evaluate Analgesic Efficacy of Fast Release AspirinCompletedNCT01117636Phase 3
- Study in Chronic Kidney Disease (CKD) Not on DialysisCompletedNCT01110629Phase 3
- Multiple Dose Escalation Study (14 Days) to Investigate Safety, Tolerability, PK and PD of Vardenafil and BAY60-4552CompletedNCT01110590Phase 1
- Therapeutic Effectiveness of Vardenafil in Patients With Erectile Dysfunction and Metabolic Syndrome in Daily Clinical PracticeCompletedNCT01106118
- Cross Over Study to Prove Bioequivalence Between Two Brands of Cefalexin SuspensionCompletedNCT01105208Phase 1
- Hepatocellular Carcinoma - Advanced Stage - Sorafenib Trial in Taiwanese PatientsCompletedNCT01098760Phase 4
- Moxifloxacin i.v. in the Treatment of Complicated Intra-Abdominal Infection (cIAI)CompletedNCT01096511
- Cross -Over Study to Prove Bioequivalence Between Two Oral Formulations of LevonorgestrelCompletedNCT01096498Phase 1
- Cross-over Study to Prove Bioequivalence Between Two Oral Formulations of LevonorgestrelCompletedNCT01096485Phase 1
- Phase I Study of BAY73-4506 in Chinese Patients With Advanced, Refractory Solid TumorsCompletedNCT01096030Phase 1
- GARDIAN, Gadovist in Routine Diagnostic Magnetic Resonance Imaging Administration in Non-selected PatientsCompletedNCT01095081
- NEBIDO in Symptomatic Late Onset Hypogonadism (SLOH)TerminatedNCT01092858Phase 4
- MiCo - Mirena or Conventional Medical Treatment for MenorrhagiaCompletedNCT01085487
- Relative Bioavailability, Transdermally Administered EE and GSD, 3 Applications SitesCompletedNCT01083264Phase 1
- Pharmacokinetic Study Comparing Aspirin and Effervescent AspirinCompletedNCT01081353Phase 1
- Prospective, Multicenter Non Interventional Study to Evaluate Adherence to Betaferon Over a 2 Years PeriodCompletedNCT01076595
- Comparative Trial in Hormone Withdrawal Associated SymptomsCompletedNCT01076582Phase 3
- Cross-over Study to Prove Bioequivalence Between Two Oral Formulations of Levonorgestrel 1.5 mgCompletedNCT01073904Phase 1
- Bioavailability, Food Effect and Safety, Tolerability of a New Oral Suspension in Comparison to the Marketed Moxifloxacin Tablet in Healthy AdultsCompletedNCT01073891Phase 1
- Cross-over Study to Prove Bioequivalence Between Two Brands of Cefalexin CapsulesCompletedNCT01073553Phase 1
- Cross-over Study to Prove Bioequivalence Between Two Brands of Cefalexin SuspensionCompletedNCT01073540Phase 1
- To Evaluate the Safety, Tolerability, Pulmonary Deposition, Pharmacokinetics and Pharmacodynamics of Ciprofloxacin Inhale in Japanese Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD, GOLD II-III)CompletedNCT01072942Phase 1
- Pharmacokinetic Study Comparing Aspirin and Aspirin GranulesCompletedNCT01072604Phase 1
- QOLBET Quality Of Life in Patients With Early Relapsing-remitting Multiple Sclerosis Treated With BETaferon® in KoreaWithdrawnNCT01071694
- Survey to Assess Why People Are Not Responding to Treatment in HypertensionCompletedNCT01071681
- FOCUS (Nifedipine GITS's Effect on Central Pressure Assessed by Applanation Tonometry)CompletedNCT01071122Phase 4
- BAY88-8223, Alpharadin, Breast Cancer Patients With Bone Dominant DiseaseCompletedNCT01070485Phase 2
- Dose Escalating Study With BAY43-9006 With Carboplatin, Paclitaxel and Bevacizumab in Untreated Stage IIIb Non-small Cell Lung Cancer (NSCLC)CompletedNCT01069328Phase 1
- A Phase IIb Study to Investigate the Efficacy and Tolerability of Lower Doses Cinaciguat (25 µg/h, 10 µg/h) Given Intravenously to Patients With Acute Decompensated Chronic Congestive Heart Failure (ADHF)TerminatedNCT01067859Phase 2
- Clinical Study to Evaluate the Maximum Tolerated Dose of BAY79-4620 Given Every 2 Weeks to Patients With Advanced Solid TumorsTerminatedNCT01065623Phase 1
- BAY58-2667 Dose Finding Trial Investigating Fixed Doses in Patients With Acute Decompensated Chronic Congestive Heart Failure (ADHF)TerminatedNCT01065077Phase 2
- Angeliq Regulatory Post Marketing SurveillanceCompletedNCT01064453
- A Phase IIb Study to Investigate the Efficacy and Tolerability of Cinaciguat (150 µg/h, 100 µg/h, 50 µg/h) Given Intravenously to Subjects With Acute Decompensated Chronic Congestive Heart Failure (ADHF)TerminatedNCT01064037Phase 2
- Placebo and Active Controlled Study to Assess Efficacy and Tolerability of Aspirin Plus PseudoephedrineCompletedNCT01062360Phase 3
- Hypertension Study of Ventavis® Inhalation Therapy in the Treatment of Patients With Pulmonary Arterial Hypertension (VENIS)CompletedNCT01062282
- Bioequivalence Study of BAY77-1931 GranuleCompletedNCT01053676Phase 1
- Study to Evaluate the Safety and Pharmacokinetics of Inhaled Ciprofloxacin in Patients With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01052298Phase 1
- Gadobutrol Magnevist-controlled Body StudyCompletedNCT01050829Phase 3
- Safety, Tolerability and Pharmacokinetics of Single Dose Intravenous Moxifloxacin in Pediatric PatientsCompletedNCT01049022Phase 1
- BAY12-8039, iv/Oral Pulmonary Abscess/Aspiration PneumoniaCompletedNCT01045902Phase 3
- Evaluation of ZK 6032924 in Probable Alzheimer's Disease Patients Versus Healthy Volunteers and the Radiation Dosimetry of ZK 6032924 in Healthy VolunteersCompletedNCT01035164Phase 1
- Symptomatic Treatment of Common Cold SymptomsCompletedNCT01033526Phase 4
- Telephone Interview of Patients That Participated in the the Pivotal Betaferon MS Trial.CompletedNCT01031459
- Bioequivalence Study: 3 mg Estradiol Valerate (EV) With and Without Levomefolate CalciumCompletedNCT01031355Phase 1
- Evaluation of the Positron Emission Tomography (PET) Tracer ZK 6032924 in Patients With Multiple Sclerosis Compared to Healthy VolunteersCompletedNCT01031199Phase 1
- Xarelto Regulatory Post-Marketing SurveillanceCompletedNCT01029743
- To Determine Maximum Tolerated Dose of BAY79-4620 in Patients With Advanced Solid TumorsCompletedNCT01028755Phase 1
- Placebo and Active Controlled, Double Dummy Study to Prove Efficacy of Aspirin in Treatment of Acute Low Back PainCompletedNCT01028079Phase 3
- Safety, Tolerability and Pharmacokinetics of Aerosolized Amikacin in Intubated and Mechanically-ventilated Patients With Nosocomial PneumoniaCompletedNCT01021436Phase 2
- Influence of Moxifloxacin on QTc Interval in Healthy Subjects for Positive Control ValidationCompletedNCT01014247Phase 1
- Comparative Safety and Efficacy Study of New Bifonazol Spray vs Terbinafine Solution vs PlaceboCompletedNCT01013909Phase 2
- Regulatory Post Marketing Surveillance Study on Nexavar®CompletedNCT01012011
- Prevent/Delay Development of Type 2 Diabetes in Subjects With Impaired Glucose Homeostasis Treated With Acarbose in Primary CareCompletedNCT01010100Phase 3
- Evaluation of the Neuroinflammation Pattern of BAY85-8102 F-18, DPA-714 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of F 18, DPA-714 in Healthy VolunteersCompletedNCT01009359Phase 1
- Drug-Eluting Balloon Catheters and the Treatment of Peripheral Arterial Occlusive DiseaseCompletedNCT01007578Phase 1
- A Study to Determine the Correct Dose of Amikacin Which is Delivered Directly to the Lungs of Ventilated Patients as an Aerosol Via an Investigational Device Called the Pulmonary Delivery Device System (PDDS)CompletedNCT01004445Phase 2
- Safety Study of BAY73-4506 in Patients With Hepatocellular CarcinomaCompletedNCT01003015Phase 2
- The Effect of Food (High Fat and Low Fat Breakfast) on the Pharmacokinetics of RegorafenibCompletedNCT01002378Phase 1
- Silica Gel Fiber Wound Dressing for Chronic Venous Leg UlcersTerminatedNCT00998673Phase 2
- Regulatory Post Marketing Surveillance Study on YAZCompletedNCT00998257
- Avelox in Complicated Skin and Skin Structure InfectionsCompletedNCT00997997
- Low-dose Nifedipine-Valsartan Combination Compared to Up-titrated Valsartan Monotherapy in Essential HypertensionCompletedNCT00993109Phase 4
- Effects of Drospirenone-containing or -Not Containing Combined Oral Contraceptives on General and Sexual Well-beingCompletedNCT00988910
- CAPRIVI: Community Acquired Pneumonia: Treatment With Avelox® in Hospitalized PatientsCompletedNCT00987792
- Birth Control Patch StudyCompletedNCT00984789Phase 3
- Sinecort Pilot Efficacy StudyCompletedNCT00980135Phase 2
- Positron Emission Tomography/Computed Tomography (PET/CT) Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-4367 in Patients With Prostate Cancer and Healthy VolunteersTerminatedNCT00975299Phase 1
- BAY59-7939 Japanese in Atrial Fibrillation (2nd)CompletedNCT00973323Phase 2
- BAY59-7939 in Atrial Fibrillation Once Daily (OD)CompletedNCT00973245Phase 2
- Glucose Reduction by Early Acarbose Treatment in Basal InsulinCompletedNCT00970528Phase 4
- Pharmacokinetics Study Comparing Naproxen Sodium Extended Release and NaprelanCompletedNCT00969449Phase 1